. 2021 Aug 17;59(4):206–210. doi: 10.5114/reum.2021.108430
Copyright: © 2021 Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie
This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Fig. 1.
Bone mineral density (BMD) modification after 18 months of therapy with rituximab.